Attention given to enterococci as one of the most important pathogens is increasing, similarly the incidence of enterococcal bacteremia also appears to be increasing. We investigated risk factors, clinical features, isolated species, and outcome
according to high-level aminoglycoside resistance in 27 cases of enterococcal bacteremia retrospectively.
Isolates were E. faecalis (17 strains), E. faecium (6 strains), E. avium (2 strains) and E. hirae (2 strains). High-level resistance to gentamicin, kanamycin, and streptomycin was found at the level of 56%, 74% and 59%, respectively. Enterococcal
bacteremia was most common in newborns (44% of patients). And the mean age of 14 adults (52% of patients) was 48 years. All patients had underlying conditions such as low birth weights caused premature delivery (7 cases), postoperative states (6
cases),
complicated delivery of neonates (5 cases), malignancies (4 cases). Twelve (44%) patients showed polymicrobial bacteremia. Antimicrobial therapy was done prior to enterococcal bacteremia in 19 (70%) of patients. Six (22%) of the patients. Six
(22%)
of
the patients died during hospitalization, but there were no fatal cases in the perinatal patients.
In summary, enterococcal bacteremia commonly occurred in perinatal and adult patients with underlying diseases. While the prognosis of perinatal patients was excellent, the mortality rate of adult patients with serious underlying diseases was 43%
(6/14). However, it is uncertain whether enterococcal bacteremia was a significant cause of mortality.
|